ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,085Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 1107

$1.59M Total Retail Price of All Prescriptions

Rank: 16 out of 1107

789 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 789 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

28% of this provider’s 789 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 21,416 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,631 1,103 S3 1 1
LEVOTHYROXINE SODIUM 1,180 1,028 2 3
OMEPRAZOLE 848 632 3 4
FUROSEMIDE 779 612 4 7
LISINOPRIL 733 623 5 2
SIMVASTATIN 652 570 6 5
ATORVASTATIN CALCIUM 495 438 7 13
AMLODIPINE BESYLATE 475 379 8 6
CITALOPRAM HBR 437 360 9 17
POTASSIUM CHLORIDE 419 354 10 14
METOPROLOL TARTRATE 401 327 11 10
ATENOLOL 400 368 12 19
PRAVASTATIN SODIUM 382 306 13 12
GABAPENTIN 368 232 14 9
EXELON 365 351 15 103
MELOXICAM 321 223 16 25
METFORMIN HCL 314 246 17 8
NAMENDA 302 302 18 42
NEXIUM 278 216 19 18
HYDROCHLOROTHIAZIDE 278 234 19 11
WARFARIN SODIUM 274 246 21 15
ALPRAZOLAM 248 123 22 87
RANITIDINE HCL 244 156 23 21
ALLOPURINOL 233 149 24 36
TAMSULOSIN HCL 231 218 25 30
ZOLPIDEM TARTRATE 226 132 26 22
TRAMADOL HCL 209 135 27 26
SINGULAIR 205 152 28 65
CRESTOR 199 114 29 23
CLOPIDOGREL 196 155 30 28
PREDNISONE 185 167 31 40
METOPROLOL SUCCINATE 183 168 32 16
CARVEDILOL 180 171 33 27
PROAIR HFA 179 124 34 37
DONEPEZIL HCL 178 160 35 32
CLONIDINE HCL 174 130 36 53
NAPROXEN 171 137 37 80
CELEBREX 169 110 38 85
SERTRALINE HCL 166 125 39 20
PLAVIX 164 131 40 39
ISOSORBIDE MONONITRATE ER 159 156 41 34
CYMBALTA 157 104 42 50
NOVOLIN 70-30 152 147 43 209
PROMETHAZINE HCL 151 103 R 44 44
GLIPIZIDE 150 133 45 64
DIOVAN 150 147 45 51
SPIRIVA 142 76 47 57
AMOXICILLIN 142 113 47 90
AMLODIPINE BESYLATE-BENAZEPRIL 141 122 49 77
LEVOFLOXACIN 140 123 50 71
JANUVIA 137 128 51 60
EXFORGE 134 118 52 221
LANSOPRAZOLE 132 101 53 102
KLOR-CON M20 131 115 54 75
CYCLOBENZAPRINE HCL 130 61 R 55 56
LIPITOR 128 127 56 109
ALBUTEROL SULFATE 125 60 57 144
OXYCODONE-ACETAMINOPHEN 124 109 S2 58 104
AMITRIPTYLINE HCL 122 67 R 59 48
POLYETHYLENE GLYCOL 3350 121 106 60 46
ALENDRONATE SODIUM 119 94 61 41
MONTELUKAST SODIUM 119 85 61 118
LOSARTAN-HYDROCHLOROTHIAZIDE 119 92 61 66
TRAZODONE HCL 118 102 64 33
ESCITALOPRAM OXALATE 118 76 64 82
IBUPROFEN 117 98 66 63
AZITHROMYCIN 117 96 66 35
MECLIZINE HCL 116 94 68 114
SULFAMETHOXAZOLE-TRIMETHOPRIM 116 94 68 88
INSULIN SYRINGE 111 84 70 78
QUETIAPINE FUMARATE 109 93 71 94
VERAPAMIL ER 106 85 72 113
LORAZEPAM 104 93 73 155
DIGOXIN 101 89 74 52
FLUTICASONE PROPIONATE 99 77 75 38
FLUOXETINE HCL 97 72 76 47
CARBIDOPA-LEVODOPA 93 82 77 122
PAROXETINE HCL 88 78 78 45
CARTIA XT 86 74 79 355
FENTANYL 86 48 S2 79 105
GLIPIZIDE XL 80 69 81 166
METOLAZONE 80 79 81 217
NITROGLYCERIN PATCH 78 78 83 184
LOSARTAN POTASSIUM 78 66 83 29
LOVASTATIN 77 57 85 55
METHOCARBAMOL 77 27 R 85 142
CIPROFLOXACIN HCL 76 68 87 59
RISPERIDONE 75 63 88 79
RAMIPRIL 74 70 89 84
PANTOPRAZOLE SODIUM 73 67 90 30
ACTOS 73 64 90 132
ACETAMINOPHEN-CODEINE 73 61 S3 90 120
DIOVAN HCT 71 55 93 106
SYNTHROID 69 61 94 70
HUMULIN 70-30 68 58 95 266
SEROQUEL 67 64 96 182
CLONAZEPAM 67 32 96 220
PHENYTOIN SODIUM EXTENDED 67 40 96 147
TRIAMTERENE-HYDROCHLOROTHIAZID 66 63 99 185
TRIAMCINOLONE ACETONIDE 65 59 100 137
LOVAZA 65 65 100 101
TIZANIDINE HCL 65 0 100 73
VENLAFAXINE HCL ER 61 19 103 117
SOTALOL 61 53 103 222
JANUMET 59 57 105 197
ROPINIROLE HCL 57 57 106 69
ADVAIR DISKUS 57 43 106 54
ENDOCET 56 16 S2 108 91
FAMOTIDINE 54 40 109 111
GLYBURIDE 54 31 R 109 68
LACTULOSE 54 54 109 89
NOVOLOG 54 48 109 127
BUMETANIDE 54 37 109 123
VYTORIN 52 36 114 169
METOCLOPRAMIDE HCL 52 29 114 116
NOVOLOG MIX 70-30 51 20 116 264
DILTIAZEM ER 51 44 116 139
BUDESONIDE 51 43 116 291
KLOR-CON M10 50 39 119 159
TEKTURNA 50 38 119 256
VENTOLIN HFA 50 45 119 97
FINASTERIDE 50 50 119 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.